Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Human Genetics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00439-013-1383-3PMID 24190013PMCID PMC4063682
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hereditary ovarian cancer

  2026cited by this paper
• 生活習慣病とgenome-wide association study

  2015cited by this paper
• Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

  2013cited by this paper
• The Mutational Landscape of Adenoid Cystic Carcinoma

  2013cited by this paper
• GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

  2013cited by this paper
• Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

  2013cited by this paper
• Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository

  2013cited by this paper
• Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies

  2013cited by this paper
• KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis.

  2012cited by this paper
• Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

  2012cited by this paper
• Rethinking ovarian cancer: recommendations for improving outcomes

  2011cited by this paper
• Calculator for ovarian carcinoma subtype prediction

  2011cited by this paper
• Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling

  2011cited by this paper
• Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian Study

  2011cited by this paper
• Estimates of array and pool-construction variance for planning efficient DNA-pooling genome wide association studies

  2011cited by this paper
• The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling

  2011cited by this paper
• Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma.

  2011cited by this paper
• The inherited genetics of ovarian and endometrial cancer.

  2010cited by this paper
• Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

  2010cited by this paper
• Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.

  2010cited by this paper
• The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

  2010cited by this paper
• Molecular characterization of ovarian cancer by gene-expression profiling.

  2010cited by this paper
• Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian Study

  2010influential reference
• Common variants at 19p13 are associated with susceptibility to ovarian cancer

  2010cited by this paper
• A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1

  2010cited by this paper
• A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

  2010cited by this paper
• ARID1A mutations in endometriosis-associated ovarian carcinomas.

  2010cited by this paper
• ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production

  2010cited by this paper
• Ovarian intestinal-type mucinous borderline tumors: a nomenclature change is long overdue.

  2010cited by this paper
• Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.

  2009cited by this paper
• Hereditary ovarian cancer.

  2009cited by this paper
• SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies

  2009cited by this paper
• Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma

  2009cited by this paper
• Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma

  2009cited by this paper
• A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2

  2009cited by this paper
• A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary

  2009cited by this paper
• Ovarian carcinoma pathology and genetics: recent advances.

  2009cited by this paper
• A genome-wide analysis identifies genetic variants in the RELN gene associated with otosclerosis.

  2009cited by this paper
• Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma

  2009cited by this paper
• Multimarker analysis and imputation of multiple platform pooling-based genome-wide association studies

  2008cited by this paper
• Common sequence variants on 20q11.22 confer melanoma susceptibility

  2008cited by this paper
• Mixed Ovarian Epithelial Carcinomas With Clear Cell and Serous Components are Variants of High-grade Serous Carcinoma: An Interobserver Correlative and Immunohistochemical Study of 32 Cases

  2008cited by this paper
• Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

  2008cited by this paper
• Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

  2008cited by this paper
• Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies.

  2007cited by this paper
• PLINK: a tool set for whole-genome association and population-based linkage analyses.

  2007cited by this paper
• World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs

  2005cited by this paper
• The role of hMSH3 and hMSH6 in ovarian endometrioid carcinoma and relationship with microsatellite instability phenotype.

  2004cited by this paper
• Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.

  2004cited by this paper
• Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.

  2004cited by this paper
• Pathology and Genetics of Tumours of the Breast and Female Genital Organs

  2003cited by this paper
• Three new human members of the lipid transfer/lipopolysaccharide binding protein family (LT/LBP)

  2002cited by this paper
• Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer

  2001cited by this paper
• World Health Organization classification of tumors

  2000cited by this paper
• Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.

  1998cited by this paper
• Hereditary ovarian cancer. Pedigree studies, Part II.

  1991cited by this paper
• Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II.

  1988cited by this paper
• Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). II. Biomarker studies

  1985cited by this paper
• Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

  year unknowncited by this paper

• Subgroups of pelvic pain are differentially associated with endometriosis and inflammatory comorbidities: a latent class analysis.

  2024cites this paper
• Transcriptomic Analyses and Experimental Validation Identified Immune-Related lncRNA–mRNA Pair MIR210HG–BPIFC Regulating the Progression of Hypertrophic Cardiomyopathy

  2024cites this paper
• The rs2275913 polymorphism of the interleukin-17A gene is associated with the risk of ovarian endometriosis

  2023cites this paper
• Identification of peripheral blood immune infiltration signatures and construction of monocyte-associated signatures in ovarian cancer and Alzheimer's disease using single-cell sequencing

  2023cites this paper
• Genetic polymorphisms in gynecologic cancers

  2021cites this paper
• Systematic Profiling of Alternative Splicing Events in Ovarian Cancer

  2021cites this paper
• The Tristetraprolin Family of RNA-Binding Proteins in Cancer: Progress and Future Prospects

  2020cites this paper
• Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort

  2018cites this paper
• Ovarian Cancer Prevention and Screening.

  2018cites this paper
• Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

  2018cites this paper
• Comparison of stage III mucinous and serous ovarian cancer: a case-control study

  2018cites this paper
• Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1

  2018cites this paper
• Genetic biomarkers for precision medicine in age-related macular degeneration

  2018cites this paper
• Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration

  2017cites this paper
• Harmonization of clinical and laboratory data to improve biomarker discovery in endometriosis: WERF EPHect

  2017cites this paper
• Genome-wide association studies and clinical outcome in ovarian cancer patients: validation in an independent cohort

  2017influential citation
• Genetic risk factors for ovarian cancer and their role for endometriosis risk.

  2017cites this paper
• C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease

  2017cites this paper
• Rethinking ovarian cancer genomics: where genome-wide association studies stand?

  2017cites this paper
• Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy

  2016cites this paper
• GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration

  2016cites this paper
• A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer

  2015cites this paper
• Loss of heterozygosity: what is it good for?

  2015cites this paper
• Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary

  2015cites this paper
• Evidence of androgen action in endometrial and ovarian cancers.

  2014cites this paper
• World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research

  2014cites this paper